Significance of electrocardiographic changes caused by the selective adenosine A2A receptor agonist regadenoson assessed by cardiac PET MPI

被引：0
|
作者：
Maewal, Param [1 ]
Brophey, Michael [1 ]
Farukhi, Irfan [1 ]
DeLaPena, Rosinda [1 ]
Thompson, Chiarra [1 ]
机构：
[1] Dallas VA Med Ctr, VA North Texas Hlth Care Ctr, Nucl Med, Dallas, TX USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1166
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adenosine A2A receptor agonist (regadenoson) in human lung transplantation
    Lau, Christine L.
    Beller, Jared P.
    Boys, Joshua A.
    Zhao, Yunge
    Phillips, Jennifer
    Cosner, Michael
    Conaway, Mark R.
    Petroni, Gina
    Charles, Eric J.
    Mehaffey, J. H.
    Mannem, Hannah C.
    Kron, Irving L.
    Krupnick, Alexander S.
    Linden, Joel
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (06): : 563 - 570
  • [2] Detection of coronary stenosis with myocardial contrast echocardiography using regadenoson, a selective adenosine A2A receptor agonist
    Le, D. Elizabeth
    Bragadeesh, Thanjavur
    Zhao, Yan
    Wang, Yue-Gang
    Zha, Daogang
    Kaul, Sanjiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2012, 13 (04) : 298 - 308
  • [3] Safety of a new selective adenosine A2A receptor agonist, binodenoson, compared to adenosine
    Heller, GV
    Gibbons, RJ
    Wackers, FJ
    Barrett, R
    Johnson, J
    Udelson, JE
    CIRCULATION, 2003, 108 (17) : 351 - 351
  • [4] Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans
    Lieu, Hsiao D.
    Shryock, John C.
    von Mering, Gregory O.
    Gordi, Toufigh
    Blackburn, Brent
    Olmsted, Ann W.
    Belardinelli, Luiz
    Kerensky, Richard A.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2007, 14 (04) : 514 - 520
  • [5] Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans
    Hsiao D. Lieu
    John C. Shryock
    Gregory O. von Mering
    Toufigh Gordi
    Brent Blackburn
    Ann W. Olmsted
    Luiz Belardinelli
    Richard A. Kerensky
    Journal of Nuclear Cardiology, 2007, 14 : 514 - 520
  • [6] The synthesis and biological activity of a highly selective adenosine A2a receptor agonist
    Borcherding, DR
    Lentz, NL
    Weintraub, PM
    Dudley, MW
    Secrest, R
    Kastner, PR
    Peet, NP
    NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (10): : 2175 - 2191
  • [7] Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist
    Hodgson, John Mcb.
    Dib, Nabil
    Kern, Morton J.
    Bach, Richard G.
    Barrett, Richard J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (11): : 1507 - 1512
  • [8] Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist
    Zhao, Gong
    Messina, Eric
    Xu, Xiaobin
    Ochoa, Manuel
    Sun, Hai-Ling
    Leung, Kwan
    Shryock, John
    Belardinelli, Luiz
    Hintze, Thomas H.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (06) : 369 - 375
  • [9] The adenosine A2A receptor agonist regadenoson decreases activation of invariant NKT cells in human sickle cell subjects
    Lin, Gene
    Field, Joshua
    Neuberg, Donna
    Nathan, David
    Linden, Joel
    FASEB JOURNAL, 2012, 26
  • [10] Effects of Age, Gender, Obesity, and Diabetes on the Efficacy and Safety of the Selective A2A Agonist Regadenoson Versus Adenosine in Myocardial Perfusion Imaging Integrated ADVANCE-MPI Trial Results
    Cerqueira, Manuel D.
    Nguyen, Patricia
    Staehr, Peter
    Underwood, S. Richard
    Iskandrian, Ami E.
    JACC-CARDIOVASCULAR IMAGING, 2008, 1 (03) : 307 - 316
12345